Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 82868-084

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 82868-084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (82868 084 30 Rev A 08 25 Nhc)

Label for Metoprolol Succinate Extended-Release Tablets USP, 50 mg strength. The label indicates a package of 30 tablets with Rx-only status. Manufactured and repackaged by Northwind Health Company, LLC, it includes storage instructions, dosage caution, and barcode information. The label also mentions the extended-release formulation and lot-specific details.*

FDA Label Image

Meto-figure.jpg (Meto Figure)

A forest plot showing results for subgroups in the MERIT-HF study. The plot compares relative risk and 95% confidence intervals for total mortality, all-cause hospitalization, and combined total mortality or hospitalization for heart failure between metoprolol succinate extended-release tablets and placebo across various patient subgroups including U.S. vs non-U.S., NYHA classifications, ejection fraction levels, ischemic etiology, sex, ethnicity, myocardial infarction history, diabetes status, hypertension history, and heart rate groups.*

FDA Label Image

Meto-structure.jpg (Meto Structure)

Chemical structure diagram showing the molecular formula of Metoprolol Succinate, the active ingredient in the Metoprolol Succinate extended-release tablets by Northwind Health Company, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.